Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 20131275)

1.

Deletion of either CD55 or CD97 ameliorates arthritis in mouse models.

Hoek RM, de Launay D, Kop EN, Yilmaz-Elis AS, Lin F, Reedquist KA, Verbeek JS, Medof ME, Tak PP, Hamann J.

Arthritis Rheum. 2010 Apr;62(4):1036-42. doi: 10.1002/art.27347.

PMID:
20131275
2.

Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue.

Hamann J, Wishaupt JO, van Lier RA, Smeets TJ, Breedveld FC, Tak PP.

Arthritis Rheum. 1999 Apr;42(4):650-8.

PMID:
10211878
3.

CD97 neutralisation increases resistance to collagen-induced arthritis in mice.

Kop EN, Adriaansen J, Smeets TJ, Vervoordeldonk MJ, van Lier RA, Hamann J, Tak PP.

Arthritis Res Ther. 2006;8(5):R155.

4.

Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue.

Kop EN, Kwakkenbos MJ, Teske GJ, Kraan MC, Smeets TJ, Stacey M, Lin HH, Tak PP, Hamann J.

Arthritis Rheum. 2005 Feb;52(2):442-50.

PMID:
15693006
6.

Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.

Visser L, de Vos AF, Hamann J, Melief MJ, van Meurs M, van Lier RA, Laman JD, Hintzen RQ.

J Neuroimmunol. 2002 Nov;132(1-2):156-63.

PMID:
12417446
7.

Therapeutic antibody targeting of CD97 in experimental arthritis: the role of antigen expression, shedding, and internalization on the pharmacokinetics of anti-CD97 monoclonal antibody 1B2.

de Groot DM, Vogel G, Dulos J, Teeuwen L, Stebbins K, Hamann J, Owens BM, van Eenennaam H, Bos E, Boots AM.

J Immunol. 2009 Sep 15;183(6):4127-34. doi: 10.4049/jimmunol.0901253. Epub 2009 Aug 28.

8.

Triggering of the dsRNA sensors TLR3, MDA5, and RIG-I induces CD55 expression in synovial fibroblasts.

Karpus ON, Heutinck KM, Wijnker PJ, Tak PP, Hamann J.

PLoS One. 2012;7(5):e35606. doi: 10.1371/journal.pone.0035606. Epub 2012 May 10.

9.

Expression of CD97 and CD55 in human medullary thyroid carcinomas.

Mustafa T, Klonisch T, Hombach-Klonisch S, Kehlen A, Schmutzler C, Koehrle J, Gimm O, Dralle H, Hoang-Vu C.

Int J Oncol. 2004 Feb;24(2):285-94.

PMID:
14719104
10.

Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55.

Karpus ON, Veninga H, Hoek RM, Flierman D, van Buul JD, Vandenakker CC, vanBavel E, Medof ME, van Lier RA, Reedquist KA, Hamann J.

J Immunol. 2013 Apr 1;190(7):3740-8. doi: 10.4049/jimmunol.1202192. Epub 2013 Feb 27.

11.

Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice.

Miwa T, Maldonado MA, Zhou L, Sun X, Luo HY, Cai D, Werth VP, Madaio MP, Eisenberg RA, Song WC.

Am J Pathol. 2002 Sep;161(3):1077-86.

12.

The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).

Hamann J, Vogel B, van Schijndel GM, van Lier RA.

J Exp Med. 1996 Sep 1;184(3):1185-9.

13.

Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.

Hamann J, Stortelers C, Kiss-Toth E, Vogel B, Eichler W, van Lier RA.

Eur J Immunol. 1998 May;28(5):1701-7.

PMID:
9603477
14.

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.

Arthritis Rheum. 2004 Feb;50(2):650-9.

PMID:
14872510
15.

Molecular cloning and characterization of mouse CD97.

Hamann J, van Zeventer C, Bijl A, Molenaar C, Tesselaar K, van Lier RA.

Int Immunol. 2000 Apr;12(4):439-48.

16.

Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.

Yoo SA, Yoon HJ, Kim HS, Chae CB, De Falco S, Cho CS, Kim WU.

Arthritis Rheum. 2009 Feb;60(2):345-54. doi: 10.1002/art.24289.

PMID:
19180491
17.

CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells.

Boulday G, Hamann J, Soulillou JP, Charreau B.

Transplantation. 2002 Feb 15;73(3):429-36.

PMID:
11884941
18.

Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.

Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L, Senices M, Wu PW, Sibley B, Leathurby Y, Brown TP, Nickerson-Nutter C, Keith JC Jr, Collins M.

Arthritis Rheum. 2007 Apr;56(4):1152-63.

PMID:
17393408
19.

Expression and function of junctional adhesion molecule-C in human and experimental arthritis.

Palmer G, Busso N, Aurrand-Lions M, Talabot-Ayer D, Chobaz-P├ęclat V, Zimmerli C, Hammel P, Imhof BA, Gabay C.

Arthritis Res Ther. 2007;9(4):R65.

20.

Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.

Abbott RJ, Spendlove I, Roversi P, Fitzgibbon H, Knott V, Teriete P, McDonnell JM, Handford PA, Lea SM.

J Biol Chem. 2007 Jul 27;282(30):22023-32. Epub 2007 Apr 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk